Kurt H Kruger - Net Worth and Insider Trading
Kurt H Kruger Net Worth
The estimated net worth of Kurt H Kruger is at least $486 dollars as of 2024-06-05. Kurt H Kruger is the Director of Qualigen Therapeutics Inc and owns about 1,800 shares of Qualigen Therapeutics Inc (QLGN) stock worth over $486. Details can be seen in Kurt H Kruger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kurt H Kruger has not made any transactions after 2021-08-19 and currently still holds the listed stock(s).
Transaction Summary of Kurt H Kruger
Kurt H Kruger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kurt H Kruger owns 2 companies in total, including Ritter Pharmaceuticals Inc (RTTR) , and Qualigen Therapeutics Inc (QLGN) .
Click here to see the complete history of Kurt H Kruger’s form 4 insider trades.
Insider Ownership Summary of Kurt H Kruger
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RTTR | Ritter Pharmaceuticals Inc | 2020-06-06 | director |
QLGN | Qualigen Therapeutics Inc | 2021-08-19 | director |
Kurt H Kruger Latest Holdings Summary
Kurt H Kruger currently owns a total of 1 stock. Kurt H Kruger owns 1,800 shares of Qualigen Therapeutics Inc (QLGN) as of August 19, 2021, with a value of $486.
Latest Holdings of Kurt H Kruger
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
QLGN | Qualigen Therapeutics Inc | 2021-08-19 | 1,800 | 0.27 | 486 |
Holding Weightings of Kurt H Kruger
Kurt H Kruger Form 4 Trading Tracker
According to the SEC Form 4 filings, Kurt H Kruger has made a total of 3 transactions in Qualigen Therapeutics Inc (QLGN) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Qualigen Therapeutics Inc is the acquisition of 800 shares on August 19, 2021, which cost Kurt H Kruger around $9,840.
Insider Trading History of Kurt H Kruger
- 1
Kurt H Kruger Trading Performance
GuruFocus tracks the stock performance after each of Kurt H Kruger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kurt H Kruger is -8.81%. GuruFocus also compares Kurt H Kruger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kurt H Kruger within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kurt H Kruger's insider trading performs compared to the benchmark.
Performance of Kurt H Kruger
Kurt H Kruger Ownership Network
Ownership Network List of Kurt H Kruger
Ownership Network Relation of Kurt H Kruger
Kurt H Kruger Owned Company Details
What does Ritter Pharmaceuticals Inc do?
Who are the key executives at Ritter Pharmaceuticals Inc?
Kurt H Kruger is the director of Ritter Pharmaceuticals Inc. Other key executives at Ritter Pharmaceuticals Inc include 10 percent owner Sekisui Diagnostics, Llc , director & Chairman & President & CEO Michael S. Poirier , and Vice President of Finance & CFO Christopher L. Lotz .
Ritter Pharmaceuticals Inc (RTTR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ritter Pharmaceuticals Inc (RTTR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ritter Pharmaceuticals Inc (RTTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ritter Pharmaceuticals Inc (RTTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ritter Pharmaceuticals Inc Insider Transactions
Kurt H Kruger Mailing Address
Above is the net worth, insider trading, and ownership report for Kurt H Kruger. You might contact Kurt H Kruger via mailing address: 100 Foxborough Blvd, Suite 240, Foxborough Ma 02035.